四妙勇安汤对ApoE~(-/-)动脉粥样硬化小鼠IL-6和MCP-1的影响 : = Effect of Simiao Yongan Decoction on IL-6 and MCP-1 in ApoE~(-/-)Atherosclerotic Mice
目的:研究四妙勇安汤对高脂饲料喂养的ApoE基因敲除小鼠动脉粥样硬化炎症反应的干预作用。方法:采用高脂饲料喂养ApoE~(-/-)小鼠14周制备动脉粥样硬化模型,成模后随机分为5组:模型组,阳性药组(阿托伐他汀,2.57 mg·kg~(-1)),四妙勇安汤高剂量组(34.9 g·kg~(-1))、四妙勇安汤中剂量组(23.14 g·kg~(-1))和四妙勇安汤低剂量组(11.61 g·kg~(-1)),分别灌胃给药12周,同时以C57BL/6小鼠为正常对照组,给予去离子水灌胃12周。采用生化仪检测三酰甘油(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)和低密度脂蛋白胆固醇(LDL-C)含量;HE染色观察主动脉血管形态,并测量主动脉内膜厚度(IT)、中膜厚度(MT)、血管管腔面积(LA)、粥样斑块面积(PA)、内中膜厚度比(IT/MT)、管腔狭窄率(PA/LA);采用流式高通量多因子检测技术检测血清中白介素-6(IL-6)、单核细胞趋化蛋白-1(MCP-1)炎症细胞因子表达。结果:与对照组相比,模型组小鼠血清TC、TG、LDL-C明显提高,HDL-C明显降低,PA、IT及IT/MT明显升高(P<0.01)。与模型组比较,四妙勇安汤能够明显降低ApoE~(-/-)小鼠主动脉PA、IT及IT/MT(P<0.01),并明显降低IL-6及MCP-1表达(P<0.01、P<0.05),但对血脂水平无明显的影响。结论:四妙勇安汤可以通过抑制炎症反应防治动脉粥样硬化,而不依赖血脂水平的变化。.
Objective:To study the intervention effect of Simiao Yongan decoction on atherosclerotic inflammatory response in ApoE knockout mice fed with high fat diet.Methods:ApoE~(-/-)mice were fed with high-fat diet for 14 weeks to prepare atherosclerosis model.After modeling,they were randomly divided into 5 groups:model group,positive drug group(atorvastatin,2.57 mg·kg~(-1)),Simiao Yongan decoction high dose group(34.9 g·kg~(-1)),Simiao Yongan decoction medium dose group(23.14 g·kg~(-1))and Simiao Yongan low dose group(11.61 g·kg~(-1)),respectively,administered by stomach 12 weeks.At the same time,C57 BL/6 mice were used as the normal control group,and deionized water was administered for 12 weeks.Using biochemical analyzer to detect triglyceride(TG),total cholesterol(TC),high-density lipoprotein cholesterol(HDL-C)and low-density lipoprotein cholesterol(low-density lipoprotein cholesterol,LDL-C)content;HE staining to observe aortic vascular morphology,and measurement of aortic intima thickness(IT),medial thickness(MT),vascular lumen area(LA),atheroma area(PA)intima-media thickness ratio(IT/MT),lumen stenosis rate(PA/LA);interleukin-6(IL-6)and mononuclear serum,and expression of inflammatory cytokines by monocyte chemoattractant protein-1(MCP-1)were measured by flow-through high-throughput multifactor detection.Results:Compared with the control group,serum TC,TG and LDL-C in the model group were significantly increased,HDL-C was significantly decreased,and PA,IT and IT/MT were significantly increased(P<0.01).Compared with the model group,Simiao Yongan decoction significantly reduced PA,IT and IT/MT(P<0.01)in ApoE~(-/-)mice,and significantly decreased IL-6 and MCP-1 expression(P<0.01,P<0.05),but had no significant effect on blood lipid levels.Conclusion:Simiao Yongan decoction can prevent atherosclerosis by inhibiting inflammatory response,independent of changes in blood lipid levels..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019-04-15 14:02 2019 |
---|---|
Erschienen: |
2019-04-15 14:02 |
Enthalten in: |
Zur Gesamtaufnahme - year:2019 |
---|---|
Enthalten in: |
Zhong guo xian dai zhong yao - (2019), 04 vom: 15 14:02. Apr., Seite 441-447 Original Letters: Enthalten in 中国现代中药 (DE-600)2999274-6 (DE-600)2999274-6 北京市 |
Reihe: |
China Academic Journals (CAJ), E, 医药卫生科技 = Medicine & Public Health |
---|
Sprache: |
Chinesisch |
---|
Weiterer Titel: |
Effect of Simiao Yongan Decoction on IL-6 and MCP-1 in ApoE~(-/-)Atherosclerotic Mice |
---|
Beteiligte Personen: |
宋珂 [VerfasserIn] |
---|
Links: |
oversea.cnki.net [lizenzpflichtig] |
---|
Anmerkungen: |
Author info:SONG Ke;HOU Yan-hong;SU Du-na;YANG Hui;BAI Yun-qi;LI Hui;LOU Li-xia;ZHAO Yi-zhou;WU Ai-ming;TU Ya;NIE Bo;Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing,Dongzhimen Hospital,Beijing University of Chinese Medicine;Research Center for Chinese Medicine Development,China Academy of Chinese Medical Sciences;China Anding Hospital,Chifeng City,Inner Mongolia;School of Chinese Materia Medica,Beijing University of Chinese Medicine |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
CAJ630517932 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | CAJ630517932 | ||
003 | DE-627 | ||
005 | 20230120074851.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230102s2019 cc |||||o 00| ||chi c | ||
035 | |a (DE-627)CAJ630517932 | ||
035 | |a (SBB-XA)CAJ_YJXX201904005 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a chi | ||
044 | |c XB-CN | ||
084 | |a ASIEN |q DE-1a |2 fid | ||
084 | |a R285.5 |2 clc | ||
100 | 0 | |a 宋珂 |e verfasserin |4 aut | |
245 | 1 | 0 | |a 四妙勇安汤对ApoE~(-/-)动脉粥样硬化小鼠IL-6和MCP-1的影响 |b = Effect of Simiao Yongan Decoction on IL-6 and MCP-1 in ApoE~(-/-)Atherosclerotic Mice |
246 | 3 | 1 | |a Effect of Simiao Yongan Decoction on IL-6 and MCP-1 in ApoE~(-/-)Atherosclerotic Mice |
264 | 1 | |c 2019-04-15 14:02 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
490 | 0 | |a China Academic Journals (CAJ) |a E |a 医药卫生科技 = Medicine & Public Health | |
500 | |a Author info:SONG Ke;HOU Yan-hong;SU Du-na;YANG Hui;BAI Yun-qi;LI Hui;LOU Li-xia;ZHAO Yi-zhou;WU Ai-ming;TU Ya;NIE Bo;Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing,Dongzhimen Hospital,Beijing University of Chinese Medicine;Research Center for Chinese Medicine Development,China Academy of Chinese Medical Sciences;China Anding Hospital,Chifeng City,Inner Mongolia;School of Chinese Materia Medica,Beijing University of Chinese Medicine | ||
520 | |a 目的:研究四妙勇安汤对高脂饲料喂养的ApoE基因敲除小鼠动脉粥样硬化炎症反应的干预作用。方法:采用高脂饲料喂养ApoE~(-/-)小鼠14周制备动脉粥样硬化模型,成模后随机分为5组:模型组,阳性药组(阿托伐他汀,2.57 mg·kg~(-1)),四妙勇安汤高剂量组(34.9 g·kg~(-1))、四妙勇安汤中剂量组(23.14 g·kg~(-1))和四妙勇安汤低剂量组(11.61 g·kg~(-1)),分别灌胃给药12周,同时以C57BL/6小鼠为正常对照组,给予去离子水灌胃12周。采用生化仪检测三酰甘油(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)和低密度脂蛋白胆固醇(LDL-C)含量;HE染色观察主动脉血管形态,并测量主动脉内膜厚度(IT)、中膜厚度(MT)、血管管腔面积(LA)、粥样斑块面积(PA)、内中膜厚度比(IT/MT)、管腔狭窄率(PA/LA);采用流式高通量多因子检测技术检测血清中白介素-6(IL-6)、单核细胞趋化蛋白-1(MCP-1)炎症细胞因子表达。结果:与对照组相比,模型组小鼠血清TC、TG、LDL-C明显提高,HDL-C明显降低,PA、IT及IT/MT明显升高(P<0.01)。与模型组比较,四妙勇安汤能够明显降低ApoE~(-/-)小鼠主动脉PA、IT及IT/MT(P<0.01),并明显降低IL-6及MCP-1表达(P<0.01、P<0.05),但对血脂水平无明显的影响。结论:四妙勇安汤可以通过抑制炎症反应防治动脉粥样硬化,而不依赖血脂水平的变化。 | ||
520 | |a Objective:To study the intervention effect of Simiao Yongan decoction on atherosclerotic inflammatory response in ApoE knockout mice fed with high fat diet.Methods:ApoE~(-/-)mice were fed with high-fat diet for 14 weeks to prepare atherosclerosis model.After modeling,they were randomly divided into 5 groups:model group,positive drug group(atorvastatin,2.57 mg·kg~(-1)),Simiao Yongan decoction high dose group(34.9 g·kg~(-1)),Simiao Yongan decoction medium dose group(23.14 g·kg~(-1))and Simiao Yongan low dose group(11.61 g·kg~(-1)),respectively,administered by stomach 12 weeks.At the same time,C57 BL/6 mice were used as the normal control group,and deionized water was administered for 12 weeks.Using biochemical analyzer to detect triglyceride(TG),total cholesterol(TC),high-density lipoprotein cholesterol(HDL-C)and low-density lipoprotein cholesterol(low-density lipoprotein cholesterol,LDL-C)content;HE staining to observe aortic vascular morphology,and measurement of aortic intima thickness(IT),medial thickness(MT),vascular lumen area(LA),atheroma area(PA)intima-media thickness ratio(IT/MT),lumen stenosis rate(PA/LA);interleukin-6(IL-6)and mononuclear serum,and expression of inflammatory cytokines by monocyte chemoattractant protein-1(MCP-1)were measured by flow-through high-throughput multifactor detection.Results:Compared with the control group,serum TC,TG and LDL-C in the model group were significantly increased,HDL-C was significantly decreased,and PA,IT and IT/MT were significantly increased(P<0.01).Compared with the model group,Simiao Yongan decoction significantly reduced PA,IT and IT/MT(P<0.01)in ApoE~(-/-)mice,and significantly decreased IL-6 and MCP-1 expression(P<0.01,P<0.05),but had no significant effect on blood lipid levels.Conclusion:Simiao Yongan decoction can prevent atherosclerosis by inhibiting inflammatory response,independent of changes in blood lipid levels. | ||
610 | 2 | 4 | |a 北京中医药大学东直门医院中医内科学教育部和北京市重点实验室 |
610 | 2 | 4 | |a 中国中医科学院中医药发展研究中心 |
610 | 2 | 4 | |a 内蒙古赤峰市安定医院 |
610 | 2 | 4 | |a 北京中医药大学中药学院 |
650 | 4 | |a 中药学、方剂学 | |
650 | 4 | |a 中医 | |
650 | 4 | |a 医药、卫生 | |
650 | 4 | |a Traditional Chinese Medicinal Herbs | |
650 | 4 | |a 医药卫生科技 | |
650 | 4 | |a Medicine & Public Health | |
650 | 4 | |a 四妙勇安汤 | |
650 | 4 | |a 动脉粥样硬化 | |
650 | 4 | |a ApoE~(-/-)小鼠 | |
650 | 4 | |a 病理 | |
650 | 4 | |a 白介素-6 | |
650 | 4 | |a 单核细胞趋化蛋白-1 | |
650 | 4 | |a Simiao Yongan decoction | |
650 | 4 | |a atherosclerosis | |
650 | 4 | |a ApoE~(-/-)mice | |
650 | 4 | |a pathology | |
650 | 4 | |a IL-6 | |
650 | 4 | |a MCP-1 | |
700 | 0 | |a 侯彦宏 |4 oth | |
700 | 0 | |a 苏都娜 |4 oth | |
700 | 0 | |a 杨会 |4 oth | |
700 | 0 | |a 白云绮 |4 oth | |
700 | 0 | |a 李慧 |4 oth | |
700 | 0 | |a 娄利霞 |4 oth | |
700 | 0 | |a 赵一舟 |4 oth | |
700 | 0 | |a 吴爱明 |4 oth | |
700 | 0 | |a 图雅 |4 oth | |
700 | 0 | |a 聂波 |4 oth | |
773 | 0 | 8 | |6 880-01 |i Enthalten in |t Zhong guo xian dai zhong yao |d Bei jing shi, 1999 |g (2019), 04 vom: 15 14:02. Apr., Seite 441-447 |h Online-Ressource |w (DE-627)CAJ000179884 |w (DE-600)2999274-6 |7 nnns |
773 | 1 | 8 | |g year:2019 |g number:04 |g day:15 14:02 |g month:04 |g pages:441-447 |
856 | 4 | 0 | |u http://erf.sbb.spk-berlin.de/han/caj/oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=YJXX201904005 |x Verlag |y CrossAsia Link |z Deutschlandweit zugänglich |
856 | 4 | 0 | |u https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=YJXX201904005 |x Verlag |z lizenzpflichtig |
880 | 0 | 8 | |6 773-01/Hans |i Enthalten in |t 中国现代中药 |d 北京市 |h Online-Ressource |w (DE-627)CAJ000179884 |w (DE-600)2999274-6 |7 nnns |
912 | |a ZDB-1-CAJ | ||
912 | |a GBV_NL_CAJ | ||
912 | |a FID-ASIEN | ||
912 | |a SSG-OLC-OA3.1 | ||
912 | |a SSG-OLC-CAJ | ||
936 | u | w | |j 2019 |e 04 |b 15 14:02 |c 04 |h 441-447 |
951 | |a AR | ||
952 | |j 2019 |e 04 |b 15 14:02 |c 04 |h 441-447 | ||
980 | |2 11 |1 01 |x 0001 |b 650022998 |c 00 |f 5:FIDXASIA |d --%%-- |e --%%-- |j --%%-- |y k |z 02-01-23 | ||
981 | |2 11 |1 01 |x 0001 |r http://erf.sbb.spk-berlin.de/han/caj/oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=YJXX201904005 |